Picture of Genetic Analysis As logo

GEAN TO 2 Genetic Analysis As Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly Speculative

Momentum

Relative Strength (%)
1m-62.6%
3m-60.61%
6m-86.32%
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-98.04%
50d MA-77.78%
200d MA-94.05%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS  /

Blurred out image of Genetic Analysis As EPS forecast chart

Profile Summary

Genetic Analysis AS is a Norway-based company active in the field of molecular diagnostics of diseases related to large and small intestine (gut) imbalances. The Company has developed a DNA-based platform technology that allows for simultaneous analysis of a number of similar (but not identical) gene fragments in one reaction. The GA-map platform technology utilizes common and variable DNA sequences within the 16S rRNA gene of the bacteria to characterize and identify the different bacteria. The technology makes it possible to generate profiles of a person's microbiota and correlate that profile to different health conditions.

Directors

    Last Annual
    Last Interim
    Incorporated
    January 1st, 1970
    Public Since
    January 1st, 1970
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    se flag iconAktieTorget Stock Exchange
    Shares in Issue
    NaN

    GEAN TO 2 Share Price Performance

    Similar to GEAN TO 2

    Picture of Genetic Analysis As logo

    Genetic Analysis As

    se flag iconAktieTorget Stock Exchange

    Picture of Genetic Analysis As logo

    Genetic Analysis As

    se flag iconAktieTorget Stock Exchange

    FAQ

    Or unlock with your email

    Or unlock with your email